Literature DB >> 1409401

Direct suppression of phagocytosis by amphipathic polymeric surfactants.

N Watrous-Peltier1, J Uhl, V Steel, L Brophy, E Merisko-Liversidge.   

Abstract

Recent studies have demonstrated that phagocytosis of colloidal particles by the mononuclear phagocytes of the liver and spleen can be controlled by either coating or stabilizing particulate carriers with the amphipathic polymeric surfactants, F108 and T908. These surfactants consist of copolymers of polypropylene oxide (PPO) and polyethylene oxide (PEO) and, when adsorbed to particulate surfaces, significantly decrease sequestration of particulates by the mononuclear phagocytes (MPS) of the liver. To evaluate these observations further, murine peritoneal macrophages were incubated for varying periods with surfactant-coated and noncoated polystyrene particles (PSPs). Phagocytosis was monitored using gamma counting and quantitative fluorescence microscopy. The data show that phagocytosis is decreased when PSPs are coated with F108 and T908. In addition, suppression of phagocytic activity was observed when cells were pretreated with the surfactant and then challenged with noncoated particles. The data confirm previous observations that polymeric surfactants consisting of PEO and PPO protect particulate carriers from rapid uptake by the MPS of the liver. Further, F108 and T908 suppress phagocytosis directly without affecting the integrity, viability, or functional state of the cell.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409401     DOI: 10.1023/a:1015855906472

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

Review 1.  Serum opsonins and liposomes: their interaction and opsonophagocytosis.

Authors:  H M Patel
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1992       Impact factor: 4.889

Review 2.  Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.

Authors:  D K Meijer; P van der Sluijs
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

3.  Biochemistry of macrophages. The first line of defence: chairman's introduction.

Authors:  Z A Cohn
Journal:  Ciba Found Symp       Date:  1986

4.  Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages.

Authors:  L Illum; L O Jacobsen; R H Müller; E Mak; S S Davis
Journal:  Biomaterials       Date:  1987-03       Impact factor: 12.479

5.  Interaction of microspheres with blood constituents. III. Macrophage phagocytosis of various types of polymeric drug carriers.

Authors:  M Kanke; R G Geissler; D Powell; A Kaplan; P P DeLuca
Journal:  J Parenter Sci Technol       Date:  1988 Sep-Oct

6.  Distribution and elimination of coated polymethyl [2-14C]methacrylate nanoparticles after intravenous injection in rats.

Authors:  D Leu; B Manthey; J Kreuter; P Speiser; P P DeLuca
Journal:  J Pharm Sci       Date:  1984-10       Impact factor: 3.534

7.  The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338).

Authors:  L Illum; S S Davis
Journal:  FEBS Lett       Date:  1984-02-13       Impact factor: 4.124

Review 8.  Nanoparticles in drug delivery.

Authors:  S J Douglas; S S Davis; L Illum
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1987       Impact factor: 4.889

9.  Acrylic microspheres in vivo IX: Blood elimination kinetics and organ distribution of microparticles with different surface characteristics.

Authors:  P Arturson; T Laakso; P Edman
Journal:  J Pharm Sci       Date:  1983-12       Impact factor: 3.534

10.  The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.

Authors:  L Illum; S S Davis; R H Müller; E Mak; P West
Journal:  Life Sci       Date:  1987-01-26       Impact factor: 5.037

View more
  3 in total

1.  Permeation of PEO-PBLA-FITC polymeric micelles in aortic endothelial cells.

Authors:  J Liaw; T Aoyagi; K Kataoka; Y Sakurai; T Okano
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

2.  Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.

Authors:  J C Neal; S Stolnik; M C Garnett; S S Davis; L Illum
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

3.  Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.

Authors:  S E Dunn; A Brindley; S S Davis; M C Davies; L Illum
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.